National
Desk
| May 20, 2003, Tuesday
Leading
Drugs for Psychosis Come Under New Scrutiny
By ERICA GOODE (NYT) 3459 words
Late Edition - Final , Section A ,
Page 1 , Column 3
ABSTRACT
- Researchers suggest that new generation of
antipsychotic drugs, called atypicals, may
not be as effective as first thought when
they were introduced 14 years ago, and may
have dangerous side effects; studies find
their superiority is at best modest,
specific to certain symptoms and variable
from drug to drug; there is increasing
suspicion that they may cause serious side
effects, notably diabetes, in some cases
leading to death; issue of risks has become
more pressing as drugs are prescribed for
children and for adults with milder
conditions; experts say drugs' benefits must
be balanced by side effects and cost; more
than 15 million prescriptions were written
last year for Zyprexa and Risperdal, two
leading drugs; when first introduced, they
appeared so successful in treating psychotic
illness that doctors began prescribing them
for other conditions, including nonpsychotic
depression, conduct disorder and severe
aggression in children; detailed look at
drugs' growth since 1990; photo; graphs;
charts (L) They were billed as near wonder
drugs, much safer and more effective in
treating schizophrenia than anything that
had come before.
For many years, it seemed that the
excitement was fully warranted.
PURCHASING
FROM NYTIMES.COM IS QUICK AND
SECURE.
To read the complete article,
simply click on one of the BUY
NOW buttons below.
You can buy
this single article or, for even
greater value, you can purchase
this article as part of a
multi-pack. You'll then have the
opportunity to buy additional
articles now or in the future at
significant savings!
Purchase
Single Article -- $2.95
Purchase as part of Article
4-Pack -- $7.95 ($1.99/article - a 33%
savings!)
Pack expires after 1 month
Purchase as part of Article
10-Pack -- $15.95 ($1.60/ article - a 46%
savings!)
Pack expires after 3 months
Purchase as part of Article
25-Pack -- $25.95 ($1.05/ article - a 65%
savings!)
Pack expires after 6 months
How multi-packs work: A
multi-pack is an archive package that saves
you money by allowing you to pre-purchase a
set number of articles in bulk at a reduced
price. You can then debit from your
multi-pack and quickly access articles from
the archive at your convenience over the
lifetime of the multi-pack.
Once you purchase an
article, you may view it as often as you
like over the next 90 days. Archive articles
do not include photos, charts or graphics
DISCLAIMER: All
information, data, and material contained, presented, or provided here is for
general information purposes only and is not to be construed as reflecting the
knowledge or opinions of the publisher, and is not to be construed or intended
as providing medical or legal advice. The decision whether or not to vaccinate
is an important and complex issue and should be made by you, and you alone, in
consultation with your health care provider.
"A foolish faith in authority is the worst enemy of truth."
-- Albert Einstein, letter to a friend, 1901
"I know of no safe depository of the ultimate powers of the society but the people themselves, and if we think them not enlightened enough to exercise control with a wholesome discretion, the remedy is not to take it from them, but to inform their discretion by education."
-- Thomas Jefferson, letter to William C. Jarvis, September 28, 1820
"What's the point of vaccination if it doesn't protect you from the unvaccinated?"
-- Sandy Gottstein
"Who gets to decide what the greater good is and how many will be sacrificed to it?"